Dyslipidemia-Induced Mitochondrial Dysfunctions in the Brains Does Not Reach Pathological Levels in the ApoE-Knockout Mice

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

ApoE4 is the strongest genetic risk factor for sporadic, late-onset Alzheimer's disease and is associated with neurodegeneration, neuronal damage, and tau phosphorylation.

“ApoE4 is the strongest genetic risk factor for sporadic, late-onset Alzheimer’s disease and is associated with neurodegeneration, neuronal damage, and tau phosphorylation [25].”

• cites [25] Carling GK, Fan L, Foxe NR, Norman K, Wong MY, Zhu D, Corona C, Razzoli A, Yu F, Yarahmady A, Ye P, Chen H, Huang Y, Amin S, Sereda R, Lopez-Lee C, Zacharioudakis L, Chen X, Xu J, Cheng F, Gavathiotis E, Cuervo AM, Holtzman DM, Mok SA, Sinha SC, Sidoli S, Ratan RR, Luo W, Gong S, Gan L (2024) Alzheimer’s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model. Neuron 112:3877-3896 e3878 sourcePartly supported

  The Introduction (page not provided) calls APOE4 the strongest genetic risk factor for late-onset AD and links it to tau toxicity and neurodegeneration. The Results (page not provided) report increased hyperphosphorylated tau and synaptic loss in female tauopathy mice with both APOE4 and TREM2 R47H; they do not establish those effects for APOE4 alone, as the citing sentence implies. (LLM, conf=0.87)

  Experimental — accuracy not yet measured

May combine two claims.

ApoE deficiency disrupts lipid homeostasis, resulting in elevated cholesterol and triglyceride levels in plasma from early adulthood.

“Conversely, ApoE deficiency disrupts lipid homeostasis, resulting in elevated cholesterol and triglyceride levels in plasma from early adulthood.”

• cites [31] Pendse AA, Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N (2009) Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. J Lipid Res 50(Suppl):S178-182 sourcePartly supported

  The “LIPOPROTEIN METABOLISM IN APOEKO MICE” section reports elevated plasma cholesterol and accumulation of cholesterol-rich remnants in apoE-deficient mice. The figure caption in “APOE IN DIABETES AND BEYOND” also describes impaired triglyceride uptake, but the copy does not establish elevated plasma triglyceride levels or specify that these changes begin in early adulthood. The claim is therefore supported for disrupted lipid metabolism and elevated cholesterol, but not for those added details. (LLM, conf=0.84)

  Experimental — accuracy not yet measured

Classified as probably not a substantial claim.

Some ApoE4 mouse phenotypes are believed to arise from an allele-specific conformation of ApoE4.

“Some of these phenotypes are believed to arise from an allele-specific conformation of ApoE4: a unique arginine at position 112 (cysteine in the other two isoforms) shifts the hinge region of the protein, enabling the N-terminal domain (residues 1–167) to directly interact with the C-terminal domain (residues 206–299) [29].”

• Also stated in: § Introduction · plain

  “This conformation plays a crucial role in the phenotype of ApoE mutant mice [30].”

• cites [29] Frieden C (2015) ApoE: the role of conserved residues in defining function. Protein Sci 24:138–144 sourcePartly supported

  The Introduction identifies arginine at position 112 as distinctive to ApoE4, and “The allosteric pathway” proposes that a change there propagates a structural difference toward the C-terminal domain. The Discussion also describes N- and C-terminal interactions. Our copy does not connect this mechanism to the cited mouse phenotypes or say that arginine 112 shifts a hinge region to enable those interactions. (LLM, conf=0.84)

  Experimental — accuracy not yet measured
• cites [30] Chen HK, Ji ZS, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ, Freedman SB, Weisgraber KH, Huang Y, Mahley RW (2011) Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J Biol Chem 286:5215–5221 sourcePartly supported

  The paper’s introduction describes an ApoE4-specific interaction between its N- and C-terminal domains mediated by Arg-112, and the Discussion links domain interaction to neurodegenerative pathology and a mild memory deficit in mice. Our copy does not say that Arg-112 shifts a hinge region or give the cited residue ranges (1–167 and 206–299). (LLM, conf=0.84)

  Experimental — accuracy not yet measured

May combine two claims.

Mice homozygous for ApoE loss-of-function alleles develop atherosclerosis and have been used as a model of cardiovascular disease due to lipid dysregulation.

“Mice homozygous for ApoE loss-of-function alleles develop atherosclerosis and have been used as a model of cardiovascular disease due to lipid dysregulation [31].”

• cites [31] Pendse AA, Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N (2009) Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. J Lipid Res 50(Suppl):S178-182 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

A hallmark of the ApoE4 mouse phenotype is reduced neuronal complexity, characterized by fewer, shorter, and less branched dendrites, including reduced dendritic spine density in the hippocampus and entorhinal cortex.

“A hallmark of the ApoE4 mouse phenotype is reduced neuronal complexity, characterized by fewer, shorter, and less branched dendrites. This includes a major reduction in dendritic spine density in the hippocampus (specifically the dentate gyrus and CA1 regions) and the entorhinal cortex [26–28].”

• cites [26] Lewandowski CT, Maldonado Weng J, LaDu MJ (2020) Alzheimer’s disease pathology in APOE transgenic mouse models: the who, what, when, where, why, and how. Neurobiol Dis 139:104811 sourcePartly supported

  The ‘APOE Transgenic Mice’ section says APOE-targeted replacement mice show isoform-dependent changes in synaptic number and structure, and the References list a study of reduced spine density and dendritic complexity in cortical neurons. Our copy does not substantiate fewer or shorter dendrites, a major reduction in spine density, or the specified hippocampal and entorhinal regions. (LLM, conf=0.82)

  Experimental — accuracy not yet measured
• cites [27] Basak JM, Kim J (2010) Differential effects of ApoE isoforms on dendritic spines in vivo: linking an Alzheimer’s disease risk factor with synaptic alterations. J Neurosci 30:4526–4527 sourcePartly supported

  In its discussion of Dumanis et al. (2009) (page unavailable), the paper reports fewer spines in APOE4 cortical neurons and shorter cortical spines in one-year-old APOE4 mice. It also explicitly reports no difference in hippocampal spine density among the APOE isoforms. The copy does not establish the claimed reduction in the dentate gyrus, CA1, or entorhinal cortex, or that the dendrites themselves were fewer and shorter. (LLM, conf=0.90)

  Experimental — accuracy not yet measured
• cites [28] Qian Z, Wang Z, Li B, Meng X, Kuang Z, Li Y, Yang Y, Ye K (2024) Thy1-ApoE4/C/EBPbeta double transgenic mice act as a sporadic model with Alzheimer’s disease. Mol Psychiatry 29:3040–3055 sourcePartly supported

  The Discussion reports attenuated dendritic arborization and spines in hippocampal CA1 neurons of nine-month-old Thy1-ApoE4/C/EBPβ double-transgenic mice compared with wild-type littermates. It does not report reduced spine density in the dentate gyrus or entorhinal cortex, or establish these findings as a general ApoE4 mouse phenotype. The Fig. 4 caption names those regions in relation to Aβ distribution, not spine density. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Classified as probably not a substantial claim.

The DCF readout is an indicator of total reactive species levels (ROS/NOS) in tissues.

“The DCF readout of the samples was used as an indicator of the total reactive species levels (ROS/NOS) present in the tissues.”

• cites [36] Murphy MP, Bayir H, Belousov V, Chang CJ, Davies KJA, Davies MJ, Dick TP, Finkel T, Forman HJ, Janssen-Heininger Y, Gems D, Kagan VE, Kalyanaraman B, Larsson NG, Milne GL, Nystrom T, Poulsen HE, Radi R, Van Remmen H, Schumacker PT, Thornalley PJ, Toyokuni S, Winterbourn CC, Yin H, Halliwell B (2022) Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat Metab 4:651–662 sourcePartly supported

  The ‘Guidelines and limitations of the detection and measurement of ROS’ section (page not provided) says DCFH can be oxidized to fluorescent DCF by several ROS, supporting its use as a nonspecific signal. But it restricts the readout to an initial assessment of changes in cellular redox state and warns that fluorescence may not increase linearly with ROS. It does not support interpreting DCF as a measure of total ROS/NOS levels in tissues. (LLM, conf=0.89)

  Experimental — accuracy not yet measured

Classified as probably not a substantial claim.

Mitochondrial alterations induced by elevated oxidative stress are key factors involved in synaptic degeneration and cell death in neurodegeneration.

“As mitochondrial alterations induced by elevated oxidative stress are key factors involved in synaptic degeneration and cell death in neurodegeneration [48, 49]”

• cites [48] Wen P, Sun Z, Gou F, Wang J, Fan Q, Zhao D, Yang L (2025) Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders. Ageing Res Rev 104:102667 sourceNot checked — no full text of the source
• cites [49] Cicali KA, Torres AK, Tapia-Rojas C (2026) Synaptic mitochondria in aging and neurodegenerative diseases: Functional decline and vulnerability. Neural Regen Res 21:2145–2152 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Excessive lipid accumulation increases oxidative stress and promotes alterations in mitophagy.

“Excessive lipid accumulation has been reported to increase oxidative stress and promote alterations in mitophagy [40, 41].”

• cites [40] Praharaj PP, Naik PP, Panigrahi DP, Bhol CS, Mahapatra KK, Patra S, Sethi G, Bhutia SK (2019) Intricate role of mitochondrial lipid in mitophagy and mitochondrial apoptosis: its implication in cancer therapeutics. Cell Mol Life Sci 76:1641–1652 sourcePartly supported

  The section “Ceramide: a critical regulator of mitophagy” (page unavailable) says that ceramide stress leads to ROS accumulation and, in glioblastoma cells, lethal mitophagy. It also describes ceramide accumulation under cellular stress. This supports the connection for a specific lipid and condition, but not the broader claim that excessive lipid accumulation generally increases oxidative stress and alters mitophagy. (LLM, conf=0.84)

  Experimental — accuracy not yet measured
• cites [41] Olivares-Vicente M, Herranz-Lopez M (2025) The interplay between oxidative stress and lipid composition in obesity-induced inflammation: antioxidants as therapeutic agents in metabolic diseases. Int J Mol Sci. https://doi.org/10.3390/ijms26178544 sourcePartly supported

  The Introduction (page unavailable) says lipid overload induces oxidative stress in adipocytes. Section 5 (page unavailable) discusses mitophagy, but links enhanced mitophagy to reduced phosphatidylcholine metabolism in macrophages; it does not establish that excessive lipid accumulation alters mitophagy. (LLM, conf=0.85)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

In ApoE4 mutant mice, mitochondrial phenotypes include increased fusion, disrupted mitophagy, and calcium overload.

“In ApoE4 mutant mice, mitochondrial phenotypes include increased fusion, disrupted mitophagy, and calcium overload [45–47].”

• cites [45] Simonovitch S, Schmukler E, Masliah E, Pinkas-Kramarski R, Michaelson DM (2019) The effects of APOE4 on mitochondrial dynamics and proteins in vivo. J Alzheimers Dis 70:861–875 sourcePartly supported

  The Conclusions (page unavailable) say that APOE4 mice show changes suggesting enhanced mitochondrial fusion and impaired mitophagy. Our copy does not report calcium overload; a search for calcium found no supporting passage. Thus, the source supports two of the three attributed phenotypes. (LLM, conf=0.88)

  Experimental — accuracy not yet measured
• cites [46] Chen H, Chen F, Jiang Y, Zhang L, Hu G, Sun F, Zhang M, Ji Y, Chen Y, Che G, Zhou X, Zhang Y (2022) A review of ApoE4 interference targeting mitophagy molecular pathways for Alzheimer’s disease. Front Aging Neurosci 14:881239 sourcePartly supported

  The ‘ApoE4 and Mitochondrial Fusion in AD’ section reports hyperfusion in ApoE4 astrocytes and elevated MFN-1 in brain tissue from young ApoE4 mice. ‘ApoE4 and Mitophagy Induction in AD’ describes altered mitophagy-related proteins in ApoE4 mice, but frames impaired mitophagy as an inference. The fusion section mentions excess calcium in the cytoplasm, not mitochondrial calcium overload in ApoE4 mice; the sentence therefore presents all three as established mouse mitochondrial phenotypes more strongly than this review supports. (LLM, conf=0.86)

  Experimental — accuracy not yet measured
• cites [47] Tambini MD, Pera M, Kanter E, Yang H, Guardia-Laguarta C, Holtzman D, Sulzer D, Area-Gomez E, Schon EA (2016) ApoE4 upregulates the activity of mitochondria-associated ER membranes. EMBO Rep 17:27–36 sourceCould not verify

  The Abstract and Results and Discussion report increased ER–mitochondrial communication and lipid synthesis in cells treated with ApoE4-containing astrocyte-conditioned media, not mitochondrial phenotypes in ApoE4 mutant mice. Searches for fusion, mitophagy, and calcium overload found no passage reporting those outcomes; the mention of mitofusin 2 concerns a knockout used to test phospholipid synthesis. (LLM, conf=0.76)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Blood-brain barrier defects have been previously reported in ApoE-knockout mice.

“Furthermore, blood–brain barrier defects have been previously reported in ApoE-knockout mice [42].”

• cites [42] Cerasuolo M, Di Meo I, Auriemma MC, Paolisso G, Papa M, Rizzo MR (2024) Exploring the dynamic changes of brain lipids, lipid rafts, and lipid droplets in aging and alzheimer’s disease. Biomolecules 14:1362 sourceCould not verify

  Section 4.3 discusses impaired lipid transport without functional ApoE, but does not report blood–brain barrier defects in ApoE-knockout mice. The passages mentioning the blood–brain barrier in sections 2.1 and 4.1 concern lipid transport and cholesterol, not defects in those mice (searched: blood–brain barrier, ApoE knockout, and permeability). (LLM, conf=0.72)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Nrf2 encodes a transcription factor responsible for activating the expression of protective enzymes.

“We also noted that the expression of Nrf2, which encodes a transcription factor responsible for activating the expression of protective enzymes, was upregulated [44].”

• cites [44] Vomund S, Schafer A, Parnham MJ, Brune B, von Knethen A (2017) Nrf2, the Master Regulator of Anti-Oxidative Responses. Int J Mol Sci 18:2772 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Accumulation of cholesterol in cultured macrophages can modulate electron transport and ATP production in the mitochondrial inner membrane.

“Preliminary studies have demonstrated that the accumulation of cholesterol in cultured macrophages can modulate electron transport and ATP production in the mitochondrial inner membrane [35].”

• cites [35] Chiu YC, Chu PW, Lin HC, Chen SK (2021) Accumulation of cholesterol suppresses oxidative phosphorylation and altered responses to inflammatory stimuli of macrophages. Biochem Biophys Rep 28:101166 sourceSupported

May combine two claims.

The Alzheimer's-like phenotype of ApoE4 mutant mice is likely allele-specific and is not attributable to ApoE loss of function.

“Together with the results of the secretase analysis (Fig. 3), these findings suggest that the Alzheimer’s-like phenotype of ApoE4 mutant mice is likely allele-specific and is not attributable to ApoE loss of function.”

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

ApoE4 targeted-replacement or humanized ApoE4 mouse models typically manifest neurological, behavioral, and molecular phenotypes that recapitulate the early stages of Alzheimer's-like pathology, often without substantial plaque or tangle formation.

“ApoE4 targeted-replacement or humanized ApoE4 mouse models typically manifest neurological, behavioral, and molecular phenotypes that recapitulate the early stages of Alzheimer’s-like pathology, often without substantial plaque or tangle formation.”

May combine two claims.

Prolonged hyperlipidemia led to impaired working memory and cognitive defects in ApoE-knockout mice.

“By contrast, the aged mutant mice exhibited a reduced alternative triplicate in the Y-maze, suggesting that prolonged hyperlipidemia led to impaired working memory and cognitive defects (Fig. 2b).”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Ldlr−/− mice manifest substantial cognitive and behavioral impairments, including age-related deterioration of spatial and working memory, due to synaptic loss and reduced neurogenesis in the brain.

“Ldlr–/– mice manifest substantial cognitive and behavioral impairments, including age-related deterioration of spatial and working memory, due to synaptic loss and reduced neurogenesis in the brain.”

• cites [17] Mulder M, Jansen PJ, Janssen BJ, van de Berg WD, van der Boom H, Havekes LM, de Kloet RE, Ramaekers FC, Blokland A (2004) Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus. Neurobiol Dis 16:212–219 sourceNot checked — no full text of the source
• cites [18] Moreira EL, de Oliveira J, Nunes JC, Santos DB, Nunes FC, Vieira DS, Ribeiro-do-Valle RM, Pamplona FA, de Bem AF, Farina M, Walz R, Prediger RD (2012) Age-related cognitive decline in hypercholesterolemic LDL receptor knockout mice (LDLr-/-): evidence of antioxidant imbalance and increased acetylcholinesterase activity in the prefrontal cortex. J Alzheimers Dis 32:495–511 sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

All animal experiments were conducted in strict accordance with IACUC regulations and ARRIVE guidelines.

“All animal experiments were conducted in strict accordance with the regulations of the Institutional Animal Care and Use Committee and Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.”

May combine two claims.

ApoE-knockout mutant mice have increased oxidative stress and mitochondrial damage.

“Increased oxidative stress in cortical tissues, and downregulated expression of the key antioxidative genes indicated increased oxidative stress and mitochondrial damage in the mutant mice.”

May combine two claims.

Ldlr−/− mice exhibit certain neurological phenotypes but do not closely recapitulate the features of the most prevalent neurodegenerative diseases.

“In summary, Ldlr–/– mice exhibit certain neurological phenotypes but do not closely recapitulate the features of the most prevalent neurodegenerative diseases.”

The quote only partly states this claim.

Neuronal death is absent in the brains of ApoE-knockout mice.

“Furthermore, the expression levels of proapoptotic genes Bax and Bak were not increased, suggesting the absence of neuronal death (Fig. 4e and f).”

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

Every effort was made to minimize animal suffering and the number of mice used.

“Every effort was made to minimize both animal suffering and the number of mice used.”

May combine two claims.

Amyloid plaque formation was not manifested by ApoE gene loss of function or by long-term dyslipidemia.

“Amyloid plaque formation was not manifested by ApoE gene loss of function or by long-term dyslipidemia.”

May combine two claims.

Cholesterol integrates into the mitochondrial membrane and influences its functions.

“We observed that the activity of the electron transport chain complex IV was reduced by 15% in the mutant mouse brains (Fig. 5), suggesting that cholesterol also integrates into the mitochondrial membrane and influences its functions.”

Probably not a substantial claim: may not pass S3 (load-bearing).

The decrease in mitochondrial mass in ApoE-knockout mutant mice is possibly due to an increase in mitophagy.

“Decreased mitochondrial mass was also observed, possibly due to the increase of mitophagy.”

Probably not a substantial claim: may not pass S3 (load-bearing).

Mitochondrial assays were conducted using a bulk-tissue design.

“In the present study, mitochondrial assays were conducted using a bulk-tissue design.”

Probably not a substantial claim: may not pass S3 (load-bearing).

The lipid content of ApoE-knockout mutant mice differs from that of wild-type mice.

“A previous study demonstrated that the lipid content of ApoE-knockout mutant mice differs from that of wild-type (WT) mice [39].”

• cites [39] Fullerton SM, Shirman GA, Strittmatter WJ, Matthew WD (2001) Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice. Exp Neurol 169:13–22 sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

Gene expression was normalized to GAPDH and presented relative to WT controls.

“Gene expression was normalized to GAPDH and presented relative to WT controls.”

May combine two claims.

Dyslipidemia induces metabolic defects and mitochondrial dysfunction in the brain, which in turn trigger neuroinflammation, synaptic loss, and cognitive defects.

“Comparison of the phenotypes observed in all three mutant mouse models with dyslipidemia suggested that dyslipidemia induces metabolic defects and mitochondrial dysfunction in the brain, which in turn trigger neuroinflammation, synaptic loss, and cognitive defects.”

Classified as probably not a substantial claim.

Activity was normalized to total mitochondrial protein content to control for variations in mitochondrial mass.

“Activity was determined spectrophotometrically and normalized to total mitochondrial protein content to control for variations in mitochondrial mass.”